Publication

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice

Scientific Reports 11:8060, 2021

Hansen HH, Grønlund RV, Baader-Pagler T, Haebel P, Tammen H, Kongskov Larsen L, Jelsing J, Vrang N, Klein T

Share this page

Resource Library

Related resources

Characterisation of age-dependent beta cell dynamics in the male db/db mice

Whole-brain activation signatures of weight-lowering drugs

Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice

Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese-diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650